283 related articles for article (PubMed ID: 29883261)
21. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells.
Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J
Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.
Dang UJ; Damsker JM; Guglieri M; Clemens PR; Perlman SJ; Smith EC; Horrocks I; Finkel RS; Mah JK; Deconinck N; Goemans NM; Haberlová J; Straub V; Mengle-Gaw L; Schwartz BD; Harper A; Shieh PB; De Waele L; Castro D; Yang ML; Ryan MM; McDonald CM; Tulinius M; Webster RI; Mcmillan HJ; Kuntz N; Rao VK; Baranello G; Spinty S; Childs AM; Sbrocchi AM; Selby KA; Monduy M; Nevo Y; Vilchez JJ; Nascimento-Osorio A; Niks EH; De Groot IJM; Katsalouli M; Van Den Anker JN; Ward LM; Leinonen M; D'Alessandro AL; Hoffman EP
Neurology; 2024 Mar; 102(5):e208112. PubMed ID: 38335499
[TBL] [Abstract][Full Text] [Related]
23. Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy.
Mavroudis PD; van den Anker J; Conklin LS; Damsker JM; Hoffman EP; Nagaraju K; Clemens PR; Jusko WJ
J Clin Pharmacol; 2019 Jul; 59(7):979-988. PubMed ID: 30742306
[TBL] [Abstract][Full Text] [Related]
24. Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
Sreetama SC; Chandra G; Van der Meulen JH; Ahmad MM; Suzuki P; Bhuvanendran S; Nagaraju K; Hoffman EP; Jaiswal JK
Mol Ther; 2018 Sep; 26(9):2231-2242. PubMed ID: 30166241
[TBL] [Abstract][Full Text] [Related]
25. VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.
Reeves EKM; Hoffman EP; Nagaraju K; Damsker JM; McCall JM
Bioorg Med Chem; 2013 Apr; 21(8):2241-2249. PubMed ID: 23498916
[TBL] [Abstract][Full Text] [Related]
26. Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
Hoffman EP; Schwartz BD; Mengle-Gaw LJ; Smith EC; Castro D; Mah JK; McDonald CM; Kuntz NL; Finkel RS; Guglieri M; Bushby K; Tulinius M; Nevo Y; Ryan MM; Webster R; Smith AL; Morgenroth LP; Arrieta A; Shimony M; Siener C; Jaros M; Shale P; McCall JM; Nagaraju K; van den Anker J; Conklin LS; Cnaan A; Gordish-Dressman H; Damsker JM; Clemens PR;
Neurology; 2019 Sep; 93(13):e1312-e1323. PubMed ID: 31451516
[TBL] [Abstract][Full Text] [Related]
27. Transgenic overexpression of miR-133a in skeletal muscle.
Deng Z; Chen JF; Wang DZ
BMC Musculoskelet Disord; 2011 May; 12():115. PubMed ID: 21615921
[TBL] [Abstract][Full Text] [Related]
28. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
[TBL] [Abstract][Full Text] [Related]
29. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
30. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
31. Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor.
Wells E; Kambhampati M; Damsker JM; Gordish-Dressman H; Yadavilli S; Becher OJ; Gittens J; Stampar M; Packer RJ; Nazarian J
Oncotarget; 2017 Feb; 8(6):9366-9374. PubMed ID: 28030841
[TBL] [Abstract][Full Text] [Related]
32. The FibromiR miR-214-3p Is Upregulated in Duchenne Muscular Dystrophy and Promotes Differentiation of Human Fibro-Adipogenic Muscle Progenitors.
Arrighi N; Moratal C; Savary G; Fassy J; Nottet N; Pons N; Clément N; Fellah S; Larrue R; Magnone V; Lebrigand K; Pottier N; Dechesne C; Vassaux G; Dani C; Peraldi P; Mari B
Cells; 2021 Jul; 10(7):. PubMed ID: 34360002
[TBL] [Abstract][Full Text] [Related]
33. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
[TBL] [Abstract][Full Text] [Related]
34. MiR-146a negatively regulates dectin-1-induced inflammatory responses.
Du L; Chen X; Duan Z; Liu C; Zeng R; Chen Q; Li M
Oncotarget; 2017 Jun; 8(23):37355-37366. PubMed ID: 28454101
[TBL] [Abstract][Full Text] [Related]
35. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
[TBL] [Abstract][Full Text] [Related]
36. miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context.
Guilbaud M; Gentil C; Peccate C; Gargaun E; Holtzmann I; Gruszczynski C; Falcone S; Mamchaoui K; Ben Yaou R; Leturcq F; Jeanson-Leh L; Piétri-Rouxel F
Skelet Muscle; 2018 Apr; 8(1):15. PubMed ID: 29703249
[TBL] [Abstract][Full Text] [Related]
37. Differential microRNA (miRNA) expression could explain microbial tolerance in a novel chronic peritonitis model.
Kanaan Z; Barnett R; Gardner S; Keskey B; Druen D; Billeter A; Cheadle WG
Innate Immun; 2013; 19(2):203-12. PubMed ID: 23060456
[TBL] [Abstract][Full Text] [Related]
38. NF-κB mediated miR-130a modulation in lung microvascular cell remodeling: Implication in pulmonary hypertension.
Li L; Kim IK; Chiasson V; Chatterjee P; Gupta S
Exp Cell Res; 2017 Oct; 359(1):235-242. PubMed ID: 28755990
[TBL] [Abstract][Full Text] [Related]
39. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
[TBL] [Abstract][Full Text] [Related]
40. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
